![Hong Sheng Xu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hong Sheng Xu
Director Ejecutivo en Shapuaisi Qiangshen Pharma Co., Ltd. .
Cargos activos de Hong Sheng Xu
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Shapuaisi Qiangshen Pharma Co., Ltd.
![]() Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - |
Historial de carrera de Hong Sheng Xu
Antiguos cargos conocidos de Hong Sheng Xu.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Director/Miembro de la Junta | 25/09/2018 | - |
Presidente | 25/09/2018 | - |
Estadísticas
Internacional
China | 3 |
Operativa
Director/Board Member | 2 |
Chairman | 1 |
Chief Executive Officer | 1 |
Sectorial
Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ZHEJIANG SHAPUAISI PHARMACEUTICAL CO.,LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
Shapuaisi Qiangshen Pharma Co., Ltd.
![]() Shapuaisi Qiangshen Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Jilin Yueshi Tianbo Pharmaceutical Co., Ltd., Shapuaisi Qiangshen Pharma Co., Ltd. manufactures tablets, hard capsules, and granules. The company is based in Dongfeng County, China. The Chinese company was founded in 2014. The CEO is Hong Sheng Xu. Shapuaisi Qiangshen Pharma Co. was acquired by Jilin Yueshi Tianbo Pharmaceutical Co., Ltd. from Zhejiang Shapuaisi Pharmaceutical Co. Ltd. on January 26, 2022 for $12.50 million. | Health Technology |
- Bolsa de valores
- Insiders
- Hong Sheng Xu
- Experiencia